MEP of the week

Lobby organisation

Novo Nordisk A/S

Business / industry · Health & pharma · HQ: Denmark · Transparency Register entry

As of 9 September 2026, Novo Nordisk A/S appears in 84 declared MEP meetings (43 different MEPs), most often with European People's Party.

84
declared meetings
with current MEPs
43
MEPs met
€2.0M/yr
declared lobbying spend
self-reported to the register
3.5
lobbyists
full time equivalent

In their own words

“Novo Nordisk is a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to serious chronic diseases. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure the diseases we treat. We employ more than 60,000 people in 80 countries, and market…”

Stated goals from the organisation's own Transparency Register filing.

Who they meet, and when

Which groups they meet

Share of this organisation's 84 declared meetings, by the meeting MEP's political group.

European People's Party3137%
Renew Europe2226%
Socialists & Democrats2125%
European Conservatives & Reformists56%
Greens/EFA45%
The Left11%

Meetings by year

Declared meetings per calendar year, 2019–2026. Bar length is relative to its busiest year (27 in 2025).

2019
1
2020
3
2021
0
2022
5
2023
8
2024
21
2025
27
2026
19

Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.

The MEPs they meet most

Tomislav Sokol
7 meetings · EPP
Stine Bosse
6 meetings · Renew
Niels Flemming Hansen
6 meetings · EPP
Christel Schaldemose
4 meetings · S&D
Morten Løkkegaard
4 meetings · Renew

The 15 most recent declared meetings

DateMEPSubject
3 Jul 2026Pierre JouvetIndustrial accelerator act
1 Jul 2026Carlo CiccioliBiotech Act
4 Jun 2026Asger ChristensenEnviroment
2 Jun 2026Kristoffer StormEU Biotech Act
2 Jun 2026Nicolás González CasaresBiotech
2 Jun 2026Wouter BekeEU Biotech Act I
28 May 2026Nicolás González CasaresBiotech
24 Apr 2026Stine BosseBiotech Act roundtable
20 Apr 2026Katri KulmuniBiotech I
17 Mar 2026Tiemo WölkenCMA
17 Mar 2026Morten LøkkegaardIntroductory meeting
4 Mar 2026Tomislav SokolHealth Policy
3 Mar 2026Sebastian Everdingcardiovascular diseases and the interrelated issues of obesity and diabetes
29 Jan 2026Sigrid FriisHealth policy
29 Jan 2026Henrik DahlEU Regulation

Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.